Investing in Vietnam’s Healthcare: what investors need to understand

This note was written following the expert-led event “Investing in Vietnam’s Healthcare Sector: Market Trends, Investor Insights, AI Applications, and Key Legal & Tax Considerations,” synthesizing the key discussions, insights, and perspectives shared by investors, operators, technology partners and advisors on the evolving healthcare landscape in Vietnam.

Why is healthcare demand in Vietnam accelerating?

Structural demand is driven by aging, income growth, and chronic diseases. Vietnam is no longer expanding basic access - it is entering long-term, specialist-led care demand.

Is this a Vietnam-only story or a regional trend?

ASEAN healthcare growth is structural; Vietnam is where it converges fastest.

📈 A rising middle class demanding private, high-quality care

📈 A rapidly aging population, reshaping the disease burden

📈 A digitally native society, increasingly intolerant of fragmented service delivery

What is changing in Vietnam’s disease profile?

Chronic conditions are replacing infectious diseases. Diabetes, cardiovascular disease, myopia, and mental health now drive long-term care needs.

⚕️ ~40% of the population is pre-diabetic

⚕️ Over 70% of 12th-grade students suffer from myopia

⚕️ Mental health and lifestyle-related conditions are rising sharply

⚕️ Urban stress and industrialization are driving respiratory and metabolic disorders

Why doesn’t capital alone scale healthcare?

Clinician shortages limit how fast platforms can grow.

🔎 Physician density: ~⅓ of U.S. levels

🔎 Severe specialty gaps: only 609 licensed psychiatrists nationwide

🔎 Geographic imbalance: HCMC has 2–3× more doctors per capita than many provinces

🔎 Training lag: a minimum 10-year cycle to produce a specialist

What legal risks do foreign investors underestimate?

🚩Foreign-invested status is determined at the operating company (OpCo) level.

If foreign ownership exceeds 50% at the OpCo level, the business is reclassified as foreign invested, triggering different licensing, land, and expansion rules.

🚩Capital requirements increase once an entity is foreign invested.

Foreign-invested healthcare facilities face minimum capital thresholds—about USD 20m for hospitals, USD 2m for policlinics, and USD 200k for specialty clinics—often impacting roll-up and outpatient strategies.

🚩Foreign ownership is broadly permitted - but with a critical exception on pharmaceutical activities.

While foreign ownership is allowed in healthcare facilities and manufacturing, foreign investors are barred from drug distribution, including hospital pharmacies, often requiring post-deal restructuring.

🚩Pharmaceutical activities carry additional compliance and margin constraints.

Each drug requires market authorization, with shared liability for quality issues, regulated pricing and margins, and prescription-only sales subject to record-keeping requirements.

🚩Healthcare licenses are tied to clinicians.

Retaining key founders and practitioners is critical to regulatory continuity and successful post-merger integration.

🚩Land and real estate create hidden long-term constraints.

In major cities, hospitals on residential or commercial land face zoning pressure and potential relocation to suburban areas.

🚩Transactions require multiple regulatory clearances.

Beyond corporate approvals, healthcare M&A may require finance authority consent, merger control clearance, and post-closing license amendments.

🚩Healthcare operations depend on multiple sub-licenses.

Hospitals and clinics require separate sub-licenses for key services, and gaps can delay integration or expansion even if the main license is valid.

Is Vietnam transforming healthcare policies?

86 laws were passed to modernize the economy, making execution faster and more predictable, shortening approvals while keeping strong regulatory control. Under Decision 1165/QĐ-TTg, national healthcare and pharmaceutical targets are explicit and measurable.

🧭 Health insurance coverage: 100% by 2030, sustained thereafter

🧭 Life expectancy: 75 years by 2030, 80+ years by 2045

🧭 Preventive care: free annual check-ups by 2026, evolving toward comprehensive population screening by 2045

Policies, capital, and technology are now explicitly aligned.

What healthcare models actually scale?

Integration beats expansion. Integrated Delivery Network (IDNs), Management Services Organization (MSO) layers, and outpatient networks outperform standalone hospitals.

🆕 Growing demand for Specialists in underserved geographies as part of Integrated Delivery Networks

🆕 New care models such as wellness-hospitality concepts tailored to elderly patients are increasingly emerging, driven by an aging population and rising incomes.

🆕 Increasing demand for medical training centers to address clinician shortages.

Leading operators are converging on a 5P framework:

• Preventive - stopping disease progression early
• Predictive - using biomarkers and AI to forecast risk
• Personalized - tailoring treatment pathways
• Participatory - engaging patients as partners
• Platform-based - unifying data across care settings

Where does technology really matter?

In a market dominated by founder-led clinics, fragmented IT stacks, and clinician-centric governance, scale does not fail because of demand or capital - it fails because there is no shared operational language. AI enables mass screening, productivity gains, and operational consistency.

🤖 Horizontal healthcare platforms sit above hospital systems, unifying data into a single decision layer for operators and investors.

🤖 They enable repeatable operating models, auditable performance, and private equity value creation.

🤖 In augmented ophthalmology, AI enables mass screening and early disease detection while boosting physician productivity up to 10×.

What kills healthcare deals after closing?

🔪 Direction mismatch between healthcare PE that often pushes fast growth, EBITDA, and standardization while medical reality favors slower growth, clinical autonomy, and organizational cultures shaped by decades of public hospital practices.

🔪 Over-pressure leads to cultural resistance, talent loss, and value erosion.

🔪 Many deals fail post-close due to weak governance and operational readiness and PMI, not valuation.

What wins in Vietnam healthcare?

In healthcare, capital alone no longer drives success, governance, operational discipline back by systems & data and regulatory alignment. 

✅ Compliance is a prerequisite, not a strategic option.

✅ Scalable healthcare is built on platforms, not star individuals.

✅ AI and operational systems are enablers best delivered through partners, not built in-house.

✅ Operational friction is constant and must be managed proactively.

✅ Long-term value depends on disciplined operations, EBITDA control, and strong post-merger integration.

The winners in Vietnam’s next healthcare decade will be those who design scalable platforms, embed regulation into their operating architecture, use technology as a scaler, and focus relentlessly on what they can control: operations, data, and governance.

👉 Investing or operating in Vietnam healthcare?

Get the structure right first, talk to our financial advisors, lawyers, tax & accounting advisors and auditors.

Download the full brief in below